Evidence map›Paper›PMID 40858803›Full record

ArticleScientific reports2025

Improving accuracy of land-use classification through MobileNetV3 and Greedy Osprey Optimization.

Jing Zhang, Ruixia Pang, Pouya Ghadesi

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jing ZhangSchool of Intelligent Engineering, Shijiazhuang Posts and Telecommunications Technical College, Shijiazhuang, 050000, Hebei, China.
Ruixia PangSchool of Intelligent Engineering, Shijiazhuang Posts and Telecommunications Technical College, Shijiazhuang, 050000, Hebei, China. langlangshan2025@126.com.
Pouya GhadesiUniversity of Mohaghegh Ardebili, Ardabil, Iran. puyyagdsy@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study presents a new efficient technique for land-use classification. The presented model uses an optimized version of MobileNetV3 architecture. The network optimization has been done based on a Greedy variant of the Osprey Optimizer (GOO). The availability of high-resolution satellite imagery has made accurate and efficient land-use classification crucial for various applications like environmental monitoring, urban planning, natural resource management, and disaster management. However, traditional approaches often suffer from low accuracy or high computational costs, making them unsuitable for large-scale datasets. To overcome these challenges, a GOO-optimized MobileNetV3 has been introduced as a lightweight yet effective solution for land-use classification. By fine-tuning the hyperparameters and weights of MobileNetV3, GOO enhances both convergence speed and model performance. The proposed model has been evaluated on three publicly available benchmark datasets and compared it against several state-of-the-art techniques, including AlexNet, HGVGG19, Joint Deep Learning, DE-UNet, Shapley Additive Explanations (SHAP). The experimental results demonstrate that the model surpasses existing models across multiple metrics. Furthermore, we conduct comprehensive ablation studies to validate the effectiveness of each component in the framework. The findings highlight the potential of combining deep learning architectures with bioinspired optimization algorithms to enhance land-use classification tasks while reducing computational complexity.

Indexed as

Deep learningGreedy osprey optimizerImage processingLand-use classificationMobileNetV3

Identifiers

PMID40858803
PMCPMC12381085

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.